- Allurion Technologies, Inc. (NYSE:ALUR) Short Interest Up 124.0% in February
Mar 14, 2026 · defenseworld.net
Allurion Technologies, Inc. (NYSE: ALUR - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 1,065,645 shares, an increase of 124.0% from the February 12th total of 475,725 shares. Based on an average daily volume of 17,038,131 shares,
- Allurion Advances Plan to Regain Listing Compliance
Mar 12, 2026 · businesswire.com
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (the “Company”) (OTCID: ALUR), a pioneer in metabolically healthy weight loss, announced today that it has appealed the decision by the New York Stock Exchange (the “NYSE”) to initiate delisting proceedings against Allurion's securities pursuant to Section 802.01B of the NYSE's Listed Company Manual, which requires listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least.
- ALLURION ADVANCES PLAN TO REGAIN LISTING COMPLIANCE
Mar 12, 2026
NATICK, MASS.--(BUSINESS WIRE)---- $ALUR--ALLURION TECHNOLOGIES, INC. (THE “COMPANY”) (OTCID: ALUR), A PIONEER IN METABOLICALLY HEALTHY WEIGHT LOSS, ANNOUNCED TODAY THAT IT HAS APPEALED THE DECISION BY THE NEW YORK STOCK EXCHANGE (THE “NYSE”) TO INITIATE DELISTING PROCEEDINGS AGAINST ALLURION'S SECURITIES PURSUANT TO SECTION 802.01B OF THE NYSE'S LISTED COMPANY MANUAL, WHICH REQUIRES LISTED COMPANIES TO MAINTAIN AN AVERAGE GLOBAL MARKET CAPITALIZATION OVER A CONSECUTIVE 30 TRADING DAY PERIOD OF AT LEAST.
- Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy
Mar 11, 2026 · businesswire.com
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (OTCID: ALUR), a pioneer in metabolically healthy weight loss, today announced that it has officially begun training and on‑boarding partner accounts across the United States, including large academic medical centers and private practices. The company has begun manufacturing FDA-approved product and expects to begin shipping in April. This milestone represents a pivotal step in the company's commercial expansion into the world's larges.
- ALLURION BEGINS TRAINING AND ON‑BOARDING OF U.S. ACCOUNTS, MARKING MAJOR MILESTONE IN EXPANSION STRATEGY
Mar 11, 2026
NATICK, MASS.--(BUSINESS WIRE)---- $ALUR--ALLURION TECHNOLOGIES, INC. (OTCID: ALUR), A PIONEER IN METABOLICALLY HEALTHY WEIGHT LOSS, TODAY ANNOUNCED THAT IT HAS OFFICIALLY BEGUN TRAINING AND ON‑BOARDING PARTNER ACCOUNTS ACROSS THE UNITED STATES, INCLUDING LARGE ACADEMIC MEDICAL CENTERS AND PRIVATE PRACTICES. THE COMPANY HAS BEGUN MANUFACTURING FDA-APPROVED PRODUCT AND EXPECTS TO BEGIN SHIPPING IN APRIL. THIS MILESTONE REPRESENTS A PIVOTAL STEP IN THE COMPANY'S COMMERCIAL EXPANSION INTO THE WORLD'S LARGES.
- NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)
Mar 6, 2026 · businesswire.com
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. NYSE Regulation reached its decision to commence proceedings to delist the Company's Securities pursuant to Section 802.01B of the NYSE's Listed Company Manual because the Company had fallen below the NYSE's.
- NYSE TO COMMENCE DELISTING PROCEEDINGS AGAINST ALLURION TECHNOLOGIES, INC. (ALUR)
Mar 6, 2026
NEW YORK--(BUSINESS WIRE)--THE NEW YORK STOCK EXCHANGE (“NYSE”, THE “EXCHANGE”) ANNOUNCED TODAY THAT THE STAFF OF NYSE REGULATION HAS DETERMINED TO COMMENCE PROCEEDINGS TO DELIST THE TWO SECURITIES ENUMERATED BELOW (“SECURITIES”) OF ALLURION TECHNOLOGIES, INC. (THE “COMPANY”) FROM THE NYSE. NYSE REGULATION REACHED ITS DECISION TO COMMENCE PROCEEDINGS TO DELIST THE COMPANY'S SECURITIES PURSUANT TO SECTION 802.01B OF THE NYSE'S LISTED COMPANY MANUAL BECAUSE THE COMPANY HAD FALLEN BELOW THE NYSE'S.
- GN Store Nord (OTCMKTS:GNNDY) and Allurion Technologies (NYSE:ALUR) Financial Survey
Mar 4, 2026 · defenseworld.net
GN Store Nord (OTCMKTS:GNNDY - Get Free Report) and Allurion Technologies (NYSE: ALUR - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Analyst Ratings This is a breakdown of
- Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
Mar 2, 2026 · businesswire.com
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, has received notice from the New York Stock Exchange (NYSE) that it intends to initiate delisting proceedings against Allurion after the Company was unable to demonstrate that it had regained compliance with Section 802.01B of the Listed Company Manual requiring listed companies to maintain either (i) at least $50 million in stockholders' equity or (ii) at le.
- ALLURION INTENDS TO APPEAL NYSE NOTICE OF DELISTING, EXECUTE PLAN TO REGAIN COMPLIANCE, AND EXPECTS TO CONTINUE TRADING ON NYSE
Mar 2, 2026
NATICK, MASS.--(BUSINESS WIRE)--ALLURION TECHNOLOGIES, INC. (THE “COMPANY”) (NYSE: ALUR), A PIONEER IN METABOLICALLY HEALTHY WEIGHT LOSS, HAS RECEIVED NOTICE FROM THE NEW YORK STOCK EXCHANGE (NYSE) THAT IT INTENDS TO INITIATE DELISTING PROCEEDINGS AGAINST ALLURION AFTER THE COMPANY WAS UNABLE TO DEMONSTRATE THAT IT HAD REGAINED COMPLIANCE WITH SECTION 802.01B OF THE LISTED COMPANY MANUAL REQUIRING LISTED COMPANIES TO MAINTAIN EITHER (I) AT LEAST $50 MILLION IN STOCKHOLDERS' EQUITY OR (II) AT LE.
